REVAGENIX INC
Federal contract awards won by REVAGENIX INC (UEI D98QFZUPFXJ9), 2020–2022 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
2
awards
$17,175,613
total value
1
agency
Agencies buying from REVAGENIX INC
What REVAGENIX INC sells
Awards
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
Department of Health and Human Services · $4,798,925 · Sep 22, 2022
TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES.
Department of Health and Human Services · $12,376,688 · Jul 1, 2020
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids